Equities

Protagenic Therapeutics Inc

Protagenic Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.50
  • Today's Change0.010 / 0.68%
  • Shares traded4.89k
  • 1 Year change-24.62%
  • Beta1.0677
Data delayed at least 15 minutes, as of May 17 2024 16:54 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4.067.9810
Total Receivables, Net------
Total Inventory------
Prepaid expenses0.140.060.69
Other current assets, total------
Total current assets4.208.0411
Property, plant & equipment, net0.120.00--
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets4.328.0411
LIABILITIES
Accounts payable0.540.620.52
Accrued expenses0.110.160.28
Notes payable/short-term debt00.340
Current portion long-term debt/capital leases------
Other current liabilities, total----0
Total current liabilities0.661.120.80
Total long term debt000.32
Total debt00.340.32
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities0.661.121.12
SHAREHOLDERS EQUITY
Common stock0.000.000.00
Additional paid-in capital353332
Retained earnings (accumulated deficit)(31)(26)(22)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.11)(0.68)(0.25)
Total equity3.676.929.94
Total liabilities & shareholders' equity4.328.0411
Total common shares outstanding4.444.324.30
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.